Rapid Micro Biosystems (RPID) Cash from Investing Activities Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.20% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -208.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -187.82% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -397.90% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -514.25% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -211.17% |
| 10 | Rapid Micro Biosystems | 89.50 Mn | 66.56 Mn | 371,000.00 | -19.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.52% |
| Dec 31, 2025 | -20.07% |
| Sep 30, 2025 | -46.57% |
| Jun 30, 2025 | -62.35% |
| Mar 31, 2025 | -20.97% |
| Dec 31, 2024 | -51.41% |
| Sep 30, 2024 | -237.18% |
| Jun 30, 2024 | 84.25% |
| Mar 31, 2024 | -2.84% |
| Dec 31, 2023 | -21.81% |
| Sep 30, 2023 | 153.35% |
| Jun 30, 2023 | 508.63% |
| Mar 31, 2023 | 113.97% |
| Dec 31, 2022 | 147.31% |
| Sep 30, 2022 | -1,846.41% |
| Jun 30, 2022 | -50.59% |
| Mar 31, 2022 | -1,121.11% |
| Dec 31, 2021 | -373.98% |
| Sep 30, 2021 | -163.79% |